InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Katkin Keith, 董事. Director active across 6 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 15 filings have been recorded. Split: 1 buy · 1 sell. Total volume traded: €125k. History available since 19 May 2021. The latest transaction was disclosed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Katkin Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
24,000 股0Common StockSEC:0001193125-26-041192:0
8,575 股0Common StockSEC:0001193125-26-015486:0
7,844 股@ US$6.30100.0% 占其流量Common StockSEC:0001367644-25-000136:0
10,000 股@ US$9.11229.8% 占其流量Common StockSEC:0000950170-25-074289:0
标准退出：2025年8月17日 (T+90)
34,403 股0Common StockSEC:0001367644-25-000106:0
25,000 股0Common StockSEC:0000950170-25-016363:0
17,430 股0Common StockSEC:0001367644-24-000089:0
17,000 股0Common StockSEC:0001562180-24-001218:0
33,847 股0Common StockSEC:0001367644-23-000105:0
16,000 股0Common StockSEC:0001562180-23-000943:0
20,782 股@ US$7.8861.6% 占其流量Common StockSEC:0001562180-22-007125:0
2,914 股@ US$7.888.6% 占其流量Common StockSEC:0001562180-22-007011:0
8,595 股0Common StockSEC:0001367644-22-000061:0
16,000 股0Common StockSEC:0001562180-22-001074:0
25,000 股0Common StockSEC:0001179110-21-005767:0
15 条申报中的 15 条
About Katkin Keith
Katkin Keith is Administrateur and reports transactions in Syndax Pharmaceuticals Inc, Emergent BioSolutions Inc., Eledon Pharmaceuticals, Inc. and RIGEL PHARMACEUTICALS INC. The record shows 15 filings, and across the 15 sampled filings the stated aggregate amounts are EUR 81115 of buys and EUR 43802 of sells, over the period from 2021-05-21 to 2026-02-06.
